


TenAces Biosciences Revenue
Biotechnology Research • Rehovot, Center District, Israel • 1-10 Employees
TenAces Biosciences revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Key Contacts at TenAces Biosciences
Ingo Hartung
Member Board Of Directors
Arnout Schepers
Founder - Ceo
Company overview
| Headquarters | Rehovot, Center District, Israel |
| Website | |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 1-10 |
About TenAces Biosciences
TenAces Biosciences is a biopharmaceutical company focused on the development of molecular glue therapeutics. Our molecular glues are small molecules that can induce or stabilize the interaction between an E3 ligase and a target protein. This enhanced binding accelerates the tagging with ubiquitin, and subsequent removal of the target protein by the proteasome. Our approach, based on machine learning, 3D modeling and virtual compound screening, allows for the development of rationally designed molecular glues for a wide range of diseases.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
TenAces Biosciences has 3 employees across 3 departments.
Departments
Number of employees
Funding Data
TenAces Biosciences has never raised funding before.
Frequently asked questions
4.8
40,000 users



